Understand the source comparison
Mechanism-Specific Peptide Categories — Direct vs Indirect Sleep Modulation
DSIP (Delta Sleep-Inducing Peptide) is the only peptide in this category with direct action on delta-wave sleep architecture. It binds to hypothalamic receptors that regulate slow-wave sleep (SWS). The restorative phase where growth hormone secretion peaks and
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- DSIP (Delta Sleep-Inducing Peptide) is the only peptide in this category with direct action on delta-wave sleep architecture. It binds to hypothalamic receptors that regulate slow-wave sleep (SWS). The restorative phase where growth hormone secretion peaks and cellular repair occurs. Animal studies show DSIP administration increases SWS duration by 22–38% and reduces sleep latency (time to fall asleep) by 12–18 minutes on average. It doesn't sedate. It shifts the brain into deeper sleep stages faster. The compound was isolated from rabbit cerebral tissue in the 1970s and named for its sleep-inducing properties, though its exact receptor remains incompletely characterised.
- Epitalon (Epithalon) works through circadian restoration, not direct sedation. It's a synthetic tetrapeptide that stimulates pineal gland function, increasing endogenous melatonin production and normalising circadian rhythm in aging subjects. Research published in Neuroendocrinology Letters found Epitalon restored melatonin rhythms in elderly patients with circadian phase delay. The biological clock misalignment that causes late-onset insomnia. It takes 7–14 days to produce measurable effects because it's addressing upstream regulatory pathways, not acting as a sleep agent itself. Researchers use it for jet lag recovery, shift work adjustment, and age-related circadian decay.
- Selank operates through GABAergic potentiation. It enhances the inhibitory neurotransmitter GABA's signalling efficiency without directly binding GABA receptors. This is mechanistically different from benzodiazepines. Selank reduces cortisol, lowers norepinephrine overactivity, and decreases the hyperarousal state that prevents sleep onset in anxiety-driven insomnia. Clinical trials show it reduces sleep latency in patients with generalised anxiety disorder but has minimal effect in subjects without baseline anxiety or stress. It's a modulator, not an inducer. Thymalin, a thymic peptide, reduces inflammatory cytokines (IL-6, TNF-alpha) that spike cortisol and fragment REM sleep. It's used in immune-compromised or chronic stress states where systemic inflammation disrupts sleep architecture indirectly.